Skip to main content
. 2022 Dec 23;102(3):313–322. doi: 10.1111/aogs.14497

TABLE 3.

Obstetrical outcomes

Outcome Finland, mean OR, % a Bpnx, n = 37 Bp, n = 15 M, n = 15 p value
Age (y) at the delivery, median (IQR) 31 29 (20–38) 32 (27–34) 30 (28–32) 0.660
Parity one 29 28 (26–33) 33 (32–36) 28 (28–28) 0.257
Multipara N/A 30 (27–33) 29 (26–34) 30 (25–36) 0.920
Ethnic: Caucasian, n (%) N/A 36 (97) 15 (100) 15 (100) 1.000
Partus, n (%) 0.367
Parity one 41 6 (16) 4 (27) 1 (7)
Multipara 59 31 (84) 11 (74) 14 (93)
First visit to maternal outpatient clinic, n (%) 0.647
First trimester N/A 23 (66)2 10 (77)2 8 (53)
Second trimester N/A 6 (17) 2 (15) 5 (33)
Third trimester N/A 6 (17) 1 (8) 2 (13)
Pregnancy complications, n (%) 0.138
Gestational diabetes mellitus 21 5 (14) 4 (27) 4 (27)
Pre‐eclampsia 4 0 1 (7) 0
Premature rupture of membranes 1 (3) 2 (13) 0
Placenta previa 0 1 (7) 0
Other b 4 (11) 0 1 (7)
Mode of delivery, n (%) 0.698
Vaginal 74 30 (81) 11 (73) 12 (80)
Instrumental 9 0 1 (7) 0
Cesarean section 17 7 (19) 3 (20) 3 (20)
Emergency, n 4 2 3
First stage of the delivery (min), median (IQR)
Parity one N/A 594 (201;730) 510 (450;510) N/A 0.724
Multipara N/A 323 (196–652)1 483 (234–746) 280 (160–350) 0.189
Second stage of the delivery (min), median (IQR)
Para one N/A 23 (13–36) 45 (34–45) N/A 0.077
Multipara N/A 9 (7–19)1 14 (6–31) 17 (8–25) 0.544

Abbreviations: Bpnx, buprenorphine‐naloxone; Bp, buprenorphine; IQR, interquartile range; M, methadone; N/A, not available; X n , missing data (n).

a

Finnish general population. 14

b

Other pregnancy complications include hypertension, infections, blood‐stained discharge, Rhesus immunization, hepatogestosis, oligohydramnios, fetal growth retardation (n = 1), and intrauterine asphyxia.